Vimarsana
Biggest News Aggregation in the World

Page 11 - Epic Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Research Today - Breaking & Trending Today

Health News - Media One Radio Group (WWSE | WJTN | WHUG | WKSN | WQFX - Vimarsana News

Health News - Media One Radio Group (WWSE | WJTN | WHUG | WKSN | WQFX

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

Source: wjtn.com
ABC Health - WOND - Vimarsana News

ABC Health - WOND

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

Health - Carroll Broadcasting Inc. - Vimarsana News

Health - Carroll Broadcasting Inc.

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

Source: wkjc.com
Health - HITS FM - Vimarsana News

Health - HITS FM

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

Source: hitsfm.net
FDA Reports Quality Lapses At Indiana Drug Factory That Novo Is Buying - Vimarsana News

FDA Reports Quality Lapses At Indiana Drug Factory That Novo Is Buying

The facility in Bloomington, Indiana, belonged to contract drugmaker Catalent. FDA inspectors found issues including a "pest" on the manufacturing line. Novo is buying Catalent to boost Wegovy production. Also: A report says FDA oversight of foreign firms making U.S. market drugs is weak.